Explore / Clinical trial
Clinical trial

Ketamine Infusion for Adolescent Depression and Anxiety

Yale UniversityCompletedPhase 4Started Oct 1, 201517 enrolledUnited StatesNCT02579928

Abstract

The purpose of this study is to determine the tolerability and short-term efficacy of a single ketamine infusion for the treatment of adolescents with 1) medication-refractory major depressive disorder (MDD) and/or 2) medication-refractory anxiety disorders (social anxiety disorder, panic disorder, generalized anxiety disorder and/or separation anxiety disorder).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepressionAnxiety

Keywords

Major Depressive DisorderSchool refusalSuicideGeneralized AnxietySuicidal IdeationMajor Depressive DisorderAnxiety Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.